Anti-obesity Drugs Market in the US 2015-2019

www.technavio.comenquiry@technavio.com

USA – CANADA – UK – CHINA – INDIA

Anti-obesity Drugs Market in the US 2015-2019

The report discusses the following in-depth:

• Market Size and Forecast

• Market Segmentation

• Buying Criteria

• Vendor Landscape

• Business Segmentation

• Geographical Segmentation

For more information on the

Anti-obesity Drugs Market in the US 2015-2019,

please mail us atenquiry@technavio.com

USA – CANADA – UK – CHINA – INDIA

Key Trends

Technavio’s Senior Analyst says, “The intense competition in the market is one of the major trends in the market. Orexigen Therapeutics's Contrave, Arena's Belviq, and Novonordisk's Saxend — all recently launched — are the major competing drugs in the US market. Another trend is the emergence of polytherapies. Polytherapies not only help in weight loss but also help to resolve many of the comorbidities associated with obesity.”

• Obesity is a complex multifactorial disorder characterized by the excessive accumulation and storage of fat in the body. In the recent years, this chronic illness is being considered as a global epidemic owing to its strikingly increasing incidence rates, especially in the in low and middle-income countries. Sedentary lifestyles and lack of physical activity coupled with consumption of high-calorie diet are considered to be the most preventable causes of obesity.

• Technavio's analysts forecast the anti-obesity drugs market in the US to grow at a CAGR of 24.52% over the period 2014-2019.

• Understanding the key drivers influencing the market

• Understanding the challenges faced by the market

• Activities of various stakeholders involved

• Key focus areas for the vendors

• Major trends that will shape the future of this market

• Vendor landscape and trajectory of the market

• Conclusion

Scope of The Report

A detailed analysis of each market driver, challenge

and trend isavailable in our report:

Anti-obesity Drugs Market in the US 2015-2019

USA – CANADA – UK – CHINA – INDIA

USA – CANADA – UK – CHINA – INDIA

Vendors

To understand the vendor landscape and for a full list of vendors view our

report:

Anti-obesity Drugs Market in the US 2015-2019

F. Hoffmann-La Roche

Orexigen Therapeutics

GlaxoSmithKline

F. Hoffmann-La Roche, a subsidiary of Roche Holding, is a healthcare company that undertakes the discovery, development, manufacturing, and marketing of innovative diagnostics and therapeutic products and services.

Orexigen Therapeutics was established in 2002 and is headquartered in California, US. It is a biopharmaceutical company that focuses on the treatment of obesity. NB32, a product of the company, has completed Phase III clinical trials for cardiovascular disease treatment.

GlaxoSmithKline was incorporated in 1999 as a result of the merger between Glaxo Wellcome and SmithKline Beecham. The company is headquartered in Brentford, Middlesex, UK. It develops, manufactures, and markets pharmaceutical products worldwide.

USA – CANADA – UK – CHINA – INDIA

Market Landscape

• The anti-obesity drugs market in the US is expected to grow at a rapid pace during the forecast period driven by the increasing prevalence of the disorder, high unmet need, and advent of new therapeutics.

• However, high trial attrition rates and product recalls will hinder market growth.

• Researchers' better understanding of the pathophysiological pathways that lead to fat accumulation has stimulated the R&D development of novel drugs, which are now in the early stages of the pipeline and will majorly contribute to market growth.

USA – CANADA – UK – CHINA – INDIA

Key Buying Criteria

• Authenticity • Delivery • Price• Service

Support

Parameter Details

Cost Anti-obesity drugs should be available at a reasonable price.

Efficacy The drugs should be able to effectively cure obesity.

Side Effects The drugs should not cause minimal side effects.

• Growth Forecasts?

• Market Analysis?

• Revenue Forecasts?

• Regional and Country level Analysis?

• Competitive Structure?

• Emerging Trends?

• Vendor Landscape?

• Other?

What Would You Like to Learn From Technavio?

Anti-obesity Drugs Market in the US 2015-2019

Let us identify your needs.We would love to hear more!

USA – CANADA – UK – CHINA – INDIA

Our Report Covers: Market Scenarios, Vendor landscape & Industry Road Maps.

You have the Option to Customize Reports & Access Analysts on every Report Purchase.

Purchasing this report?

For media enquiries,please drop us a mail at

media@technavio.com

We’ll include an hour with our analysts to discuss the report findings.

For free.

USA – CANADA – UK – CHINA – INDIA

Access the Report

USA – CANADA – UK – CHINA – INDIA

India: An Overview

USA – CANADA – UK – CHINA – INDIA

About Us

USA – CANADA – UK – CHINA – INDIA

Thank You!

North America

Chicago, USA

Phone: +1 630 333 9501  

Fax: +1 630 833 2171

Europe

London, United Kingdom

Phone: +44 208 123 1770

Fax: +44 845 280 2825

Asia

Bangalore, India

Phone: +91 934 254 0560

Fax: +91 80 4080 6070

DISCLAIMER

This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall

Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages.

Copyright ©2013 Infiniti Research Limited. All Rights Reserved.

Reproduction without written permission is completely forbidden.

NOT FOR FURTHER DISTRIBUTION